What does it mean when free thyroxine (FT4) and thyroid-stimulating hormone (TSH) levels are both elevated?

Elevated levels of free thyroxine (FT4) and thyroid-stimulating hormone (TSH) are commonly observed in central hyperthyroidism. Central hyperthyroidism is typically associated with hypothalamic or pituitary disorders, such as TSH-secreting pituitary adenomas.

A TSH-secreting pituitary adenoma is a rare, benign tumor of the pituitary gland. Clinically, it stimulates excessive TSH secretion from the pituitary, leading to thyroid enlargement and overproduction of thyroid hormones. This results in elevated serum levels of free T4 and free T3. The predominant clinical manifestations include signs and symptoms of hyperthyroidism accompanied by diffuse goiter.

Management of TSH-secreting pituitary adenomas must be individualized based on the patient’s specific clinical features. A specialist physician will determine whether radiation therapy or surgical intervention is appropriate, depending on the precise characteristics of the pituitary tumor and the presence or severity of local mass effect symptoms.